Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1986 Feb;53(2):161–173. doi: 10.1038/bjc.1986.31

Expression of MHC class II antigens in human B-cell leukaemia and non-Hodgkin's lymphoma.

K Guy, A S Krajewski, A E Dewar
PMCID: PMC2001345  PMID: 3513812

Abstract

In this review we have summarized our experiences of serological analysis of MHC class II antigen expression in human B cell malignant disease. Cells from a large number of cases of B-cell chronic lymphocytic leukaemia (CLL) and non-Hodgkin's lymphoma (NHL) have been examined for expression of class II antigens. Using a number of monoclonal antibodies which in some cases are specific for class II subregion products (DP, DQ and DR), MHC class II antigens were detected by indirect immunofluorescence and fluorescent activated cell sorter analysis in CLL and by immunohistochemical staining in NHL. At the cell surface in many cases of B cell malignant disease, products of the different class II subregion genes are non-coordinately expressed. The most commonly occurring pattern of non-coordinate expression of class II molecules is of expression of DP and DR antigens in the absence of detectable DQ expression. These findings are in contrast to normal B lymphocytes where DP, DQ and DR antigens are expressed together at the cell surface. There is considerable heterogeneity among cases comprising individual histopathological categories of B cell malignancy, and in many instances heterogeneous class II phenotypes are also found on cells from the same tumour. In chronic lymphocytic leukaemia, class II antigen expression is inducible in vitro by treating the cells with the phorbol ester TPA. CLL cells treated with TPA have much increased levels of class II antigen expression at the cell surface and much increased steady state levels of class II specific mRNA transcripts detectable with complementary DNA probes. Aberrant class II antigen expression may be involved in the pathogenesis of B cell malignant disease.

Full text

PDF
161

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Addis J. B., Tisch R., Falk J. A., Letarte M. The analysis with monoclonal antibodies of the heterogeneity of Ia glycoproteins on chronic lymphocytic leukemia cells. J Immunol. 1982 Nov;129(5):2033–2039. [PubMed] [Google Scholar]
  2. Biddison W. E., Rao P. E., Talle M. A., Goldstein G., Shaw S. Possible involvement of the T4 molecule in T cell recognition of class II HLA antigens: evidence from studies of proliferative responses to SB antigens. J Immunol. 1983 Jul;131(1):152–157. [PubMed] [Google Scholar]
  3. Bodmer J. G., Bodmer W. F. Monoclonal antibodies to HLA determinants. Br Med Bull. 1984 Jul;40(3):267–275. doi: 10.1093/oxfordjournals.bmb.a071988. [DOI] [PubMed] [Google Scholar]
  4. Brodsky F. M. A matrix approach to human class II histocompatibility antigens: reactions of four monoclonal antibodies with the products of nine haplotypes. Immunogenetics. 1984;19(3):179–194. doi: 10.1007/BF00364762. [DOI] [PubMed] [Google Scholar]
  5. Brown G., Walker L., Ling N. R., Richardson P., Johnson G. D., Guy K., Steel C. M. T-cell proliferation and expression of MHC class II antigens. Scand J Immunol. 1984 Apr;19(4):373–377. doi: 10.1111/j.1365-3083.1984.tb00944.x. [DOI] [PubMed] [Google Scholar]
  6. Corte G., Calabi F., Damiani G., Bargellesi A., Tosi R., Sorrentino R. Human Ia molecules carrying DC1 determinants differ in both alpha- and beta-subunits from Ia molecules carrying DR determinants. Nature. 1981 Jul 23;292(5821):357–360. doi: 10.1038/292357a0. [DOI] [PubMed] [Google Scholar]
  7. Cossman J., Neckers L. M., Arnold A., Korsmeyer S. J. Induction of differentiation in a case of common acute lymphoblastic leukemia. N Engl J Med. 1982 Nov 11;307(20):1251–1254. doi: 10.1056/NEJM198211113072006. [DOI] [PubMed] [Google Scholar]
  8. Daar A. S., Fuggle S. V., Fabre J. W., Ting A., Morris P. J. The detailed distribution of MHC Class II antigens in normal human organs. Transplantation. 1984 Sep;38(3):293–298. doi: 10.1097/00007890-198409000-00019. [DOI] [PubMed] [Google Scholar]
  9. Danersund A., Tötterman T. H., Nilsson K., Egle-Jansson I., Kabelitz D., Sjöberg O. Phorbol ester-induced differentiation of chronic B lymphocytic leukaemia cells--regulatory impact of autologous and allogeneic accessory cells. Clin Exp Immunol. 1985 Mar;59(3):644–652. [PMC free article] [PubMed] [Google Scholar]
  10. Edwards J. A., Jones D. B., Evans P. R., Smith J. L. Differential expression of HLA class II antigens on human fetal and adult lymphocytes and macrophages. Immunology. 1985 Jul;55(3):489–500. [PMC free article] [PubMed] [Google Scholar]
  11. Faille A., Turmel P., Charron D. J. Differential expression of HLA-DR and HLA-DC/DS molecules in a patient with hairy cell leukemia: restoration of HLA-DC/DS expression by (12-0-tetradecanoyl phorbol-13-acetate), 5 azacytidine, and sodium butyrate. Blood. 1984 Jul;64(1):33–37. [PubMed] [Google Scholar]
  12. Giles R. C., Capra J. D. Structure, function, and genetics of human class II molecules. Adv Immunol. 1985;37:1–71. doi: 10.1016/s0065-2776(08)60337-5. [DOI] [PubMed] [Google Scholar]
  13. Giles R. C., DeMars R., Chang C. C., Capra J. D. Allelic polymorphism and transassociation of molecules encoded by the HLA-DQ subregion. Proc Natl Acad Sci U S A. 1985 Mar;82(6):1776–1780. doi: 10.1073/pnas.82.6.1776. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Godal T., Henriksen A., Ruud E., Michaelsen T. Monoclonal human B lymphoma cells respond to DNA synthesis to anti-immunoglobulins in the presence of the tumour promotor TPA. Scand J Immunol. 1982 Mar;15(3):267–274. doi: 10.1111/j.1365-3083.1982.tb00648.x. [DOI] [PubMed] [Google Scholar]
  15. Gonwa T. A., Picker L. J., Raff H. V., Goyert S. M., Silver J., Stobo J. D. Antigen-presenting capabilities of human monocytes correlates with their expression of HLA-DS, an Ia determinant distinct from HLA-DR. J Immunol. 1983 Feb;130(2):706–711. [PubMed] [Google Scholar]
  16. Gordon J. Molecular aspects of immunoglobulin expression by human B cell leukemias and lymphomas. Adv Cancer Res. 1984;41:71–154. doi: 10.1016/s0065-230x(08)60015-9. [DOI] [PubMed] [Google Scholar]
  17. Goyert S. M., Silver J. Further characterization of HLA-DS molecules: implications for studies assessing the role of human Ia molecules in cell interactions and disease susceptibility. Proc Natl Acad Sci U S A. 1983 Sep;80(18):5719–5723. doi: 10.1073/pnas.80.18.5719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Groenewegen G., Buurman W. A., van der Linden C. J. Lymphokine dependence of in vivo expression of MHC class II antigens by endothelium. Nature. 1985 Jul 25;316(6026):361–363. doi: 10.1038/316361a0. [DOI] [PubMed] [Google Scholar]
  19. Gustafsson K., Emmoth E., Widmark E., Böhme J., Peterson P. A., Rask L. Isolation of a cDNA clone coding for an SB beta-chain. Nature. 1984 May 3;309(5963):76–78. doi: 10.1038/309076a0. [DOI] [PubMed] [Google Scholar]
  20. Guy K., Van Heyningen V., Cohen B. B., Deane D. L., Steel C. M. Differential expression and serologically distinct subpopulations of human Ia antigens detected with monoclonal antibodies to Ia alpha and beta chains. Eur J Immunol. 1982 Nov;12(11):942–948. doi: 10.1002/eji.1830121109. [DOI] [PubMed] [Google Scholar]
  21. Guy K., Van Heyningen V., Dewar E., Steel C. M. Enhanced expression of human Ia antigens by chronic lymphocytic leukemia cells following treatment with 12-O-tetradecanoylphorbol-13-acetate. Eur J Immunol. 1983 Feb;13(2):156–159. doi: 10.1002/eji.1830130212. [DOI] [PubMed] [Google Scholar]
  22. Halper J. P., Fu S. M., Gottlieb A. B., Winchester R. J., Kunkel H. G. Poor mixed lymphocyte reaction stimulatory capacity of leukemic B cells of chronic lymphocytic leukemia patients despite the presence of Ia antigens. J Clin Invest. 1979 Nov;64(5):1141–1148. doi: 10.1172/JCI109567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Halper J., Fu S. M., Wang C. Y., Winchester R., Kunkel H. G. Patterns of expression of human "Ia-like" antigens during the terminal stages of B cell development. J Immunol. 1978 May;120(5):1480–1484. [PubMed] [Google Scholar]
  24. Herrmann F., Dörken B., Ludwig W. D., Schwarting R. A comparison of membrane marker phenotypes in hairy-cell leukemia and phorbol-ester induced B-cll cells using monoclonal antibodies. Leuk Res. 1985;9(5):529–536. doi: 10.1016/0145-2126(85)90132-8. [DOI] [PubMed] [Google Scholar]
  25. Howard M., Paul W. E. Regulation of B-cell growth and differentiation by soluble factors. Annu Rev Immunol. 1983;1:307–333. doi: 10.1146/annurev.iy.01.040183.001515. [DOI] [PubMed] [Google Scholar]
  26. Hsu S. M., Jaffe E. S. Phenotypic expression of B-lymphocytes. 1. Identification with monoclonal antibodies in normal lymphoid tissues. Am J Pathol. 1984 Mar;114(3):387–395. [PMC free article] [PubMed] [Google Scholar]
  27. Kehrl J. H., Muraguchi A., Fauci A. S. The modulation of membrane Ia on human B lymphocytes. Cell Immunol. 1985 May;92(2):391–403. doi: 10.1016/0008-8749(85)90020-6. [DOI] [PubMed] [Google Scholar]
  28. Kilpatrick D. C., Dewar A. E., Stockdill G., Maginnis M., Jordan A., Neill G. W., Gelsthorpe K., Yap P. L. Histocompatibility antigen frequencies in patients with chronic lymphocytic leukaemia: possible identification of a subgroup with relatively benign disease. Scand J Haematol. 1984 Oct;33(4):391–396. doi: 10.1111/j.1600-0609.1984.tb00713.x. [DOI] [PubMed] [Google Scholar]
  29. Korman A. J., Boss J. M., Spies T., Sorrentino R., Okada K., Strominger J. L. Genetic complexity and expression of human class II histocompatibility antigens. Immunol Rev. 1985 Jul;85:45–86. doi: 10.1111/j.1600-065x.1985.tb01130.x. [DOI] [PubMed] [Google Scholar]
  30. Korsmeyer S. J., Greene W. C., Cossman J., Hsu S. M., Jensen J. P., Neckers L. M., Marshall S. L., Bakhshi A., Depper J. M., Leonard W. J. Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia. Proc Natl Acad Sci U S A. 1983 Jul;80(14):4522–4526. doi: 10.1073/pnas.80.14.4522. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Krajewski A. S., Guy K., Dewar A. E., Cossar D. Immunohistochemical analysis of human MHC class II antigens in B-cell non-Hodgkin's lymphomas. J Pathol. 1985 Feb;145(2):185–194. doi: 10.1002/path.1711450206. [DOI] [PubMed] [Google Scholar]
  32. Lampson L. A., Levy R. Two populations of Ia-like molecules on a human B cell line. J Immunol. 1980 Jul;125(1):293–299. [PubMed] [Google Scholar]
  33. Marti G. E., Nadler L. M., Chused T. M., Tosato G., Blaese R. M., Kindt T. J. Cellular distribution of a human I-A-like (DS/DC) antigen on normal and neoplastic lymphoid cells. Hum Immunol. 1985 Jan;12(1):23–35. doi: 10.1016/0198-8859(85)90251-4. [DOI] [PubMed] [Google Scholar]
  34. Müller C., Ziegler A., Muller C., Hadam M., Waller H. D., Wernet P., Müller G. Divergent expression of HLA-DC/MB, -DR, and -SB region products on normal and pathological tissues as detected by monoclonal antibodies. Immunobiology. 1985 Apr;169(3):228–249. doi: 10.1016/s0171-2985(85)80036-x. [DOI] [PubMed] [Google Scholar]
  35. Natali P. G., Segatto O., Ferrone S., Tosi R., Corte G. Differential tissue distribution and ontogeny of DC-1 and HLA-DR antigens. Immunogenetics. 1984;19(2):109–116. doi: 10.1007/BF00387853. [DOI] [PubMed] [Google Scholar]
  36. Newman R. A., Delia D., Greaves M. F., Navarrete C., Fainboim L., Festenstein H. Differential expression of HLA-DR and DR-linked determinants on human leukemias and lymphoid cells. Eur J Immunol. 1983 Feb;13(2):172–176. doi: 10.1002/eji.1830130215. [DOI] [PubMed] [Google Scholar]
  37. Newman R. A., Greaves M. F. Characterization of HLA-DR antigens on leukaemic cells. Clin Exp Immunol. 1982 Oct;50(1):41–50. [PMC free article] [PubMed] [Google Scholar]
  38. Nunez-Roldan A., Szer I., Toguchi T., Cuttner J., Winchester R. Association of certain Ia allotypes with the occurrence of chronic lymphocytic leukemia. Recognition by a monoclonal anti-Ia reagent of a susceptibility determinant not in the DR series. J Exp Med. 1982 Dec 1;156(6):1872–1877. doi: 10.1084/jem.156.6.1872. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Nuñez G., Ball E. J., Myers L. K., Stastny P. Allostimulating cells in man. Quantitative variation in the expression of HLA-DR and HLA-DQ molecules influences T-cell activation. Immunogenetics. 1985;22(1):85–91. doi: 10.1007/BF00430597. [DOI] [PubMed] [Google Scholar]
  40. Nuñez G., Giles R. C., Ball E. J., Hurley C. K., Capra J. D., Stastny P. Expression of HLA-DR, MB, MT and SB antigens on human mononuclear cells: identification of two phenotypically distinct monocyte populations. J Immunol. 1984 Sep;133(3):1300–1306. [PubMed] [Google Scholar]
  41. Okamura J., Gelfand E. W., Letarte M. Heterogeneity of the response of chronic lymphocytic leukemia cells to phorbol ester. Blood. 1982 Nov;60(5):1082–1088. [PubMed] [Google Scholar]
  42. Okamura J., Letarte M., Gelfand E. W. Heterogeneity of non-T, non-B acute lymphocytic leukemia defined by the quantitative expression of Ia and common all antigens. Leuk Res. 1984;8(3):335–343. doi: 10.1016/0145-2126(84)90072-9. [DOI] [PubMed] [Google Scholar]
  43. Okamura J., Letarte M., Stein L. D., Sigal N. H., Gelfand E. W. Modulation of chronic lymphocytic leukemia cells by phorbol ester: increase in Ia expression, IgM secretion and MLR stimulatory capacity. J Immunol. 1982 May;128(5):2276–2280. [PubMed] [Google Scholar]
  44. Palacios R., Guy K., Van Heyningen V. Monoclonal antibodies against HLA-DR antigens acting on stimulator cells prevent OKT8+ T lymphocytes from acquiring sensitivity to interleukin 2 and expressing suppressor function. Eur J Immunol. 1983 Jan;13(1):64–72. doi: 10.1002/eji.1830130114. [DOI] [PubMed] [Google Scholar]
  45. Pawelec G. P., Shaw S., Ziegler A., Müller C., Wernet P. Differential inhibition of HLA-D- or SB-directed secondary lymphoproliferative responses with monoclonal antibodies detecting human Ia-like determinants. J Immunol. 1982 Sep;129(3):1070–1075. [PubMed] [Google Scholar]
  46. Pawelec G., Wernet P., Rosenlund R., Blaurock M., Schneider E. M. Strong lymphoproliferative suppressive function of PLT clones specific for SB-like antigens. Hum Immunol. 1984 Mar;9(3):145–157. doi: 10.1016/0198-8859(84)90042-9. [DOI] [PubMed] [Google Scholar]
  47. Schlossman S. F., Chess L., Humphreys R. E., Strominger J. L. Distribution of Ia-like molecules on the surface of normal and leukemic human cells. Proc Natl Acad Sci U S A. 1976 Apr;73(4):1288–1292. doi: 10.1073/pnas.73.4.1288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Shaw A. R., Chan J. K., Reid S., Seehafer J. HLA-DR synthesis induction and expression in HLA-DR-negative carcinoma cell lines of diverse origins by interferon-gamma but not by interferon-beta. J Natl Cancer Inst. 1985 Jun;74(6):1261–1268. [PubMed] [Google Scholar]
  49. Shaw S., Ziegler A., DeMars R. Specificity of monoclonal antibodies directed against human and murine class II histocompatibility antigens as analyzed by binding to HLA-deletion mutant cell lines. Hum Immunol. 1985 Apr;12(4):191–211. doi: 10.1016/0198-8859(85)90336-2. [DOI] [PubMed] [Google Scholar]
  50. Srigley J., Barlogie B., Butler J. J., Osborne B., Blick M., Johnston D., Kantarjian H., Reuben J., Batsakis J., Freireich E. J. Heterogeneity of non-Hodgkin's lymphoma probed by nucleic acid cytometry. Blood. 1985 May;65(5):1090–1096. [PubMed] [Google Scholar]
  51. Swerdlow S. H., Murray L. J., Habeshaw J. A., Stansfeld A. G. Lymphocytic lymphoma/B-chronic lymphocytic leukaemia--an immunohistopathological study of peripheral B lymphocyte neoplasia. Br J Cancer. 1984 Nov;50(5):587–599. doi: 10.1038/bjc.1984.225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Trowsdale J., Kelly A. The human HLA class II alpha chain gene DZ alpha is distinct from genes in the DP, DQ and DR subregions. EMBO J. 1985 Sep;4(9):2231–2237. doi: 10.1002/j.1460-2075.1985.tb03919.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Tötterman T. H., Nilsson K., Sundström C. Phorbol ester-induced differentiation of chronic lymphocytic leukaemia cells. Nature. 1980 Nov 13;288(5787):176–178. doi: 10.1038/288176a0. [DOI] [PubMed] [Google Scholar]
  54. Wang C. Y., Al-Katib A., Lane C. L., Koziner B., Fu S. M. Induction of HLA-DC/DS (LEU 10) antigen expression by human precursor B cell lines. J Exp Med. 1983 Nov 1;158(5):1757–1762. doi: 10.1084/jem.158.5.1757. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Watson A. J., DeMars R., Trowbridge I. S., Bach F. H. Detection of a novel human class II HLA antigen. 1983 Jul 28-Aug 3Nature. 304(5924):358–361. doi: 10.1038/304358a0. [DOI] [PubMed] [Google Scholar]
  56. Ziegler A., Uchańska-Ziegler B., Zeuthen J., Wernet P. HLA antigen expression at the single cell level on a K562 X B cell hybrid: an analysis with monoclonal antibodies using bacterial binding assays. Somatic Cell Genet. 1982 Nov;8(6):775–789. doi: 10.1007/BF01543018. [DOI] [PubMed] [Google Scholar]
  57. van Heyningen V., Guy K., Newman R., Steel C. M. Human MHC class II molecules as differentiation markers. Immunogenetics. 1982;16(5):459–469. doi: 10.1007/BF00372104. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES